CoChat
Sign Up
Cited by 160

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials

Thabit, Abrar K, Crandon, Jared L, Nicolau, David P·2015·Expert Opinion on Pharmacotherapy
DOI 10.1517/14656566.2015.993381
Open this paper in CoChat — free account

Abstract

Introduction Antimicrobial resistance is a well-recognized global threat; thus, the development of strong infection control policies coupled with antimicrobial stewardship strategies and new therapies is required to reverse this process. In its 2013 report on antimicrobial resistance, the Centers for Disease Control and Prevention focused on this problem while presenting estimated annual rates of infections with antimicrobial-resistant organisms and their related mortality rates. Whereas some resistant pathogens were considered less threatening, others such as carbapenem-resistant Enterobacteriaceae were associated with higher mortality rates owing to limited treatment options. Areas covered An overview of the most common antimicrobial-resistant pathogens, focusing on risk factors for acquisition, clinical and economic outcomes, as well as current treatment options. Strategies to optimize antimicrobial therapy with currently available agents, in addition to newly developed antimicrobials are also discussed. Expert opinion The emergence of pathogens with a variety of resistance mechanisms has intensified the challenges associated with infection control and treatment strategies. Therefore, prudent use of currently available antimicrobial agents, as well as implementing measures to limit spread of resistance is paramount. Although several new antimicrobials have been recently approved or are in the pipeline showing promise in the battle against resistance, the appropriate use of…

Overview

Integrity signals

Registry

Crossref · 10.1517/14656566.2015.993381

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 2 references

Research works printed but not linked: 146

  1. Centers for Disease Control and Prevention (CDC), 2013, Antibiotic resistance threats in the United States, 2013
  2. Roberts RR, 2010, Med Care, 48, 1026, 10.1097/MLR.0b013e3181ef60a2 · DOI
  3. Roberts RR, 2009, Clin Infect Dis, 49, 1175, 10.1086/605630 · DOI
  4. 10.1016/S0140-6736(67)92346-X · DOI
  5. 10.1016/S1286-4579(00)01345-9 · DOI
  6. Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, 57, 1353
  7. Pfaller MA, 2012, Clin Infect Dis, 55, S187, 10.1093/cid/cis561 · DOI
  8. Song JH, 2012, Vaccine, 30, 2728, 10.1016/j.vaccine.2012.01.091 · DOI
  9. Pletz MW, 2011, Int J Med Microbiol, 301, 53, 10.1016/j.ijmm.2010.05.004 · DOI
  10. Van Bambeke F, 2007, Drugs, 67, 2355, 10.2165/00003495-200767160-00005 · DOI
  11. 10.1086/511159 · DOI
  12. Reynolds CA, 2014, Antimicrob Resist Infect Control, 3, 16, 10.1186/2047-2994-3-16 · DOI
  13. Tleyjeh IM, 2006, Clin Infect Dis, 42, 788, 10.1086/500140 · DOI
  14. Nuermberger E, 2004, Clin Infect Dis, 38, 99, 10.1086/380126 · DOI
  15. Ambrose PG, 2004, Clin Infect Dis, 39, 1554, 10.1086/425508 · DOI
  16. 10.1086/668770 · DOI
  17. Jarvis WR, 2010, Am J Infect Control, 40, 194, 10.1016/j.ajic.2012.02.001 · DOI
  18. Chambers HF, 2001, Postgrad Med, 109, 43
  19. Bordon J, 2010, Diagn Microbiol Infect Dis, 67, 395, 10.1016/j.diagmicrobio.2010.03.006 · DOI
  20. Cosgrove SE, 2005, Infect Control Hosp Epidemiol, 26, 166, 10.1086/502522 · DOI
  21. 10.1086/367653 · DOI
  22. Lee BY, 2013, Clin Microbiol Infect, 19, 528, 10.1111/j.1469-0691.2012.03914.x · DOI
  23. 10.1093/jac/40.1.135 · DOI · Paper page
  24. Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, 51, 565
  25. Gemmell CG, 2004, J Infect Chemother, 10, 69, 10.1007/s10156-004-0307-5 · DOI
  26. 10.1128/AAC.00380-13 · DOI
  27. Han JH, 2012, Antimicrob Agents Chemother, 56, 5164, 10.1128/AAC.00757-12 · DOI
  28. van Hal SJ, 2011, PLoS One, 6, e21217, 10.1371/journal.pone.0021217 · DOI
  29. 10.1086/596629 · DOI
  30. 10.1093/jac/dkf009 · DOI
  31. 10.1016/S1473-3099(01)00091-3 · DOI
  32. 10.1093/cid/ciq146 · DOI
  33. Flamm RK, 2013, Antimicrob Agents Chemother, 57, 1077, 10.1128/AAC.02112-12 · DOI
  34. Housman ST, 2014, Int J Antimicrob Agents, 44, 235, 10.1016/j.ijantimicag.2014.05.012 · DOI
  35. Velazquez A, 2013, Clin Microbiol Infect, 19, 1169, 10.1111/1469-0691.12171 · DOI
  36. 10.1093/jac/dks354 · DOI
  37. 10.1128/AAC.50.3.1079-1082.2006 · DOI
  38. Mehta S, 2012, Antimicrob Agents Chemother, 56, 6192, 10.1128/AAC.01525-12 · DOI · Paper page
  39. Dilworth TJ, 2014, Antimicrob Agents Chemother, 58, 102, 10.1128/AAC.01204-13 · DOI
  40. 10.1128/CMR.13.4.686-707.2000 · DOI
  41. 10.1086/321815 · DOI
  42. Song X, 2003, Infect Control Hosp Epidemiol, 24, 251, 10.1086/502196 · DOI
  43. Butler AM, 2010, Infect Control Hosp Epidemiol, 31, 28, 10.1086/649020 · DOI
  44. Cheah AL, 2013, Clin Microbiol Infect, 19, E181, 10.1111/1469-0691.12132 · DOI
  45. Stosor V, 1998, Arch Intern Med, 158, 522, 10.1001/archinte.158.5.522 · DOI
  46. Hayakawa K, 2012, Antimicrob Agents Chemother, 56, 2452, 10.1128/AAC.06299-11 · DOI
  47. Chavers LS, 2003, J Hosp Infect, 53, 159, 10.1053/jhin.2002.1375 · DOI
  48. Sader HS, 2009, Diagn Microbiol Infect Dis, 65, 158, 10.1016/j.diagmicrobio.2009.06.016 · DOI
  49. Kamboj M, 2011, Infect Control Hosp Epidemiol, 32, 391, 10.1086/659152 · DOI
  50. Scheetz MH, 2010, Pharmacotherapy, 30, 1221, 10.1592/phco.30.12.1221 · DOI
  51. 10.1086/431672 · DOI
  52. 10.1056/NEJMra041359 · DOI
  53. Knothe H, 1983, Infection, 11, 315, 10.1007/BF01641355 · DOI
  54. Hsieh CJ, 2010, J Microbiol Immunol Infect, 43, 240, 10.1016/S1684-1182(10)60038-2 · DOI
  55. Webster DP, 2011, J Antimicrob Chemother, 66, 2126, 10.1093/jac/dkr246 · DOI
  56. 10.1016/j.clinthera.2011.11.023 · DOI
  57. Lee SY, 2006, Infect Control Hosp Epidemiol, 27, 1226, 10.1086/507962 · DOI
  58. Schwaber MJ, 2006, Antimicrob Agents Chemother, 50, 1257, 10.1128/AAC.50.4.1257-1262.2006 · DOI
  59. MacVane SH, 2014, J Hosp Infect, 9, 232
  60. Tuon FF, 2011, Braz J Infect Dis, 15, 594, 10.1016/S1413-8670(11)70257-4 · DOI
  61. Bouchillon SK, 2013, Clin Ther, 35, 872, 10.1016/j.clinthera.2013.03.022 · DOI
  62. Goethaert K, 2006, Clin Microbiol Infect, 12, 56, 10.1111/j.1469-0691.2005.01290.x · DOI
  63. 10.1128/AAC.01487-06 · DOI
  64. Lee NY, 2013, Clin Infect Dis, 56, 488, 10.1093/cid/cis916 · DOI
  65. Gavin PJ, 2006, Antimicrob Agents Chemother, 50, 2244, 10.1128/AAC.00381-05 · DOI
  66. Senol S, 2010, J Chemother, 22, 355, 10.1179/joc.2010.22.5.355 · DOI
  67. Kelesidis T, 2008, J Antimicrob Chemother, 62, 895, 10.1093/jac/dkn311 · DOI
  68. Tasbakan MI, 2012, Int J Antimicrob Agents, 40, 554, 10.1016/j.ijantimicag.2012.08.003 · DOI
  69. Abraham EP, 1988, Rev Infect Dis, 10, 677, 10.1093/clinids/10.4.677 · DOI
  70. Jacoby GA, 2009, Clin Microbiol Rev, 22, 161, 10.1128/CMR.00036-08 · DOI
  71. Pfaller MA, 2006, Clin Infect Dis, 42, S153, 10.1086/500662 · DOI
  72. Pai H, 2004, Antimicrob Agents Chemother, 48, 3720, 10.1128/AAC.48.10.3720-3728.2004 · DOI
  73. Livermore DM, 2001, J Antimicrob Chemother, 48, 59, 10.1093/jac/48.suppl_1.59 · DOI
  74. 10.1093/jac/dkp493 · DOI
  75. Park YS, 2009, Int J Antimicrob Agents, 34, 38, 10.1016/j.ijantimicag.2009.01.009 · DOI
  76. Cosgrove SE, 2002, Arch Intern Med, 162, 185, 10.1001/archinte.162.2.185 · DOI
  77. Tam VH, 2009, Diagn Microbiol Infect Dis, 63, 279, 10.1016/j.diagmicrobio.2008.11.007 · DOI
  78. Tamma PD, 2013, Clin Infect Dis, 57, 781, 10.1093/cid/cit395 · DOI
  79. Nordmann P, 2012, Trends Mol Med, 18, 263, 10.1016/j.molmed.2012.03.003 · DOI
  80. Tzouvelekis LS, 1994, J Med Microbiol, 40, 403, 10.1099/00222615-40-6-403 · DOI
  81. Hope R, 2006, J Antimicrob Chemother, 58, 1312, 10.1093/jac/dkl414 · DOI
  82. Pakyz AL, 2008, Arch Intern Med, 168, 2254, 10.1001/archinte.168.20.2254 · DOI
  83. Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, 62, 165
  84. 10.3201/eid1710.110655 · DOI
  85. 10.3201/eid2007.121004 · DOI
  86. Ahn JY, 2014, Am J Infect Control, 42, 621, 10.1016/j.ajic.2014.02.024 · DOI
  87. Lee GC, 2013, Ann Pharmacother, 47, 1115, 10.1177/1060028013503120 · DOI
  88. 10.1016/j.ajic.2012.09.020 · DOI
  89. Yigit H, 2001, Antimicrob Agents Chemother, 45, 1151, 10.1128/AAC.45.4.1151-1161.2001 · DOI · Paper page
  90. 10.1016/S1473-3099(13)70190-7 · DOI
  91. Nordmann P, 2009, Lancet Infect Dis, 9, 228, 10.1016/S1473-3099(09)70054-4 · DOI
  92. Gasink LB, 2009, Infect Control Hosp Epidemiol, 30, 1180, 10.1086/648451 · DOI
  93. 10.1086/666642 · DOI
  94. 10.1086/671270 · DOI
  95. 10.1086/592412 · DOI
  96. Neuner EA, 2011, Diagn Microbiol Infect Dis, 69, 357, 10.1016/j.diagmicrobio.2010.10.013 · DOI
  97. Qureshi ZA, 2012, Antimicrob Agents Chemother, 56, 2108, 10.1128/AAC.06268-11 · DOI
  98. Bulik CC, 2011, Antimicrob Agents Chemother, 55, 3002, 10.1128/AAC.01420-10 · DOI
  99. Giamarellou H, 2013, Antimicrob Agents Chemother, 57, 2388, 10.1128/AAC.02399-12 · DOI
  100. 10.1186/1476-0711-11-32 · DOI
  101. 10.1093/cid/cis588 · DOI
  102. Sbrana F, 2013, Clin Infect Dis, 56, 697, 10.1093/cid/cis969 · DOI
  103. 10.1186/1476-0711-11-32 · DOI
  104. Neuner EA, 2012, Antimicrob Agents Chemother, 56, 5744, 10.1128/AAC.00402-12 · DOI
  105. Yong D, 2009, Antimicrob Agents Chemother, 53, 5046, 10.1128/AAC.00774-09 · DOI
  106. Nordmann P, 2011, Trends Microbiol, 19, 588, 10.1016/j.tim.2011.09.005 · DOI
  107. Pillai DR, 2011, CMAJ, 183, 59, 10.1503/cmaj.101487 · DOI
  108. European Centre for Disease Prevention and Control, 2011, Updated risk assessment on the spread of NDM and its variants within Europe
  109. Lowe CF, 2013, Infect Control Hosp Epidemiol, 34, 49, 10.1086/668778 · DOI
  110. Chien JM, 2012, Scand J Infect Dis, 44, 312, 10.3109/00365548.2011.633549 · DOI
  111. Decousser JW, 2013, Euro Surveill, 18, 10.2807/1560-7917.ES2013.18.31.20547 · DOI
  112. Nagar A, 2012, Ulster Med J, 81, 154
  113. Gaibani P, 2011, Euro Surveill, 16, 20027, 10.2807/ese.16.47.20027-en · DOI
  114. Mulvey MR, 2011, Emerg Infect Dis, 17, 103, 10.3201/eid1701.101358 · DOI
  115. Tsang KY, 2012, Hong Kong Med J, 18, 439
  116. Samuelsen Ø, 2011, J Antimicrob Chemother, 66, 670, 10.1093/jac/dkq483 · DOI
  117. Flateau C, 2012, Euro Surveill, 17, 10.2807/ese.17.45.20311-en · DOI
  118. Hoang TH, 2013, J Clin Microbiol, 51, 373, 10.1128/JCM.02322-12 · DOI
  119. Stone NR, 2011, J Antimicrob Chemother, 66, 2677, 10.1093/jac/dkr337 · DOI
  120. Zilberberg MD, 2013, J Hosp Med, 8, 559, 10.1002/jhm.2080 · DOI
  121. 10.1099/jmm.0.009142-0 · DOI
  122. Morales E, 2012, BMC Health Serv Res, 12, 122, 10.1186/1472-6963-12-122 · DOI
  123. Hirsch EB, 2010, Expert Rev Pharmacoecon Outcomes Res, 10, 441, 10.1586/erp.10.49 · DOI
  124. 10.1128/AAC.01802-13 · DOI
  125. Sabuda DM, 2008, Can J Infect Dis Med Microbiol, 19, 413, 10.1155/2008/743197 · DOI
  126. Towner KJ, 2009, J Hosp Infect, 73, 355, 10.1016/j.jhin.2009.03.032 · DOI
  127. 10.1128/CMR.00058-07 · DOI
  128. Sheng WH, 2010, Int J Infect Dis, 14, e764, 10.1016/j.ijid.2010.02.2254 · DOI
  129. Playford EG, 2007, J Hosp Infect, 65, 204, 10.1016/j.jhin.2006.11.010 · DOI
  130. Zheng YL, 2013, Am J Infect Control, 41, e59, 10.1016/j.ajic.2013.01.006 · DOI
  131. Lee NY, 2007, Infect Control Hosp Epidemiol, 28, 713, 10.1086/517954 · DOI
  132. Young LS, 2007, Infect Control Hosp Epidemiol, 28, 1247, 10.1086/521660 · DOI
  133. Queenan AM, 2012, Diagn Microbiol Infect Dis, 73, 267, 10.1016/j.diagmicrobio.2012.04.002 · DOI
  134. Sader HS, 2014, Diagn Microbiol Infect Dis, 78, 443, 10.1016/j.diagmicrobio.2013.11.025 · DOI
  135. Shin JA, 2012, Yonsei Med J, 53, 974, 10.3349/ymj.2012.53.5.974 · DOI
  136. López-Cortés LE, 2014, J Antimicrob Chemother, 69, 3119, 10.1093/jac/dku233 · DOI
  137. Crandon JL, 2011, Crit Care Clin, 27, 77, 10.1016/j.ccc.2010.11.004 · DOI
  138. 10.1128/AAC.39.3.650 · DOI
  139. Moise-Broder PA, 2004, Clin Infect Dis, 38, 1700, 10.1086/421092 · DOI
  140. Pai MP, 2014, Adv Drug Deliv Rev
  141. Dellit TH, 2007, Clin Infect Dis, 44, 159, 10.1086/510393 · DOI
  142. Oldach D, 2013, Antimicrob Agents Chemother, 57, 2526, 10.1128/AAC.00197-13 · DOI
  143. Lucasti C, 2013, J Antimicrob Chemother, 68, 1183, 10.1093/jac/dks523 · DOI
  144. Vazquez JA, 2012, Curr Med Res Opin, 28, 1921, 10.1185/03007995.2012.748653 · DOI
  145. Zhanel GG, 2014, Drugs, 74, 31, 10.1007/s40265-013-0168-2 · DOI
  146. Sutcliffe JA, 2013, Antimicrob Agents Chemother, 57, 5548, 10.1128/AAC.01288-13 · DOI

Cited by

Sorted by citations

See all 160

Metadata

Authors
Thabit, A. K., Crandon, J. L., & Nicolau, D. P.
Venue
Expert Opinion on Pharmacotherapy
Publisher
Informa UK Limited
Published
2014-12-13
Volume
16
Issue
2
Pages
159-177
ISSN
  • 1465-6566
  • 1744-7666
DOI
10.1517/14656566.2015.993381
Cited by
160
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials. https://app.cochat.ai/papers/10.1517/14656566.2015.993381
The paper
Thabit, A. K., Crandon, J. L., & Nicolau, D. P. (2015). Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials. Expert Opinion on Pharmacotherapy. https://doi.org/10.1517/14656566.2015.993381